美国Cancer Genetics, Inc. (CGI)
癌症遗传学公司（CGI）是一个个性化的医药等新兴的领导者，产品和服务，使癌症诊断和治疗是针对具体个人的遗传特征。成立于1999年由世界知名Dr. R.S.K. Chaganti博士.产品正在共同闸道介面发展将转变癌症患者管理，提高治疗效果，并减少医疗费用。共同闸道介面的先进的测试结果，以及最先进的参考实验室国家提供基因组信息，病人和他们的医生最需要的 - 诊断，监测和通报癌症治疗。

An Emerging Leader In Cancer Diagnostics

Cancer Genetics, Inc. (CGI) is an emerging leader in personalized medicine, with products and services that enable cancer diagnostics and treatment that are tailored to the specific genetic profile of the individual.

Products being developed at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs. CGI’s cutting-edge proprietary tests and state of the art reference lab provide genomic information where patients and their physicians need it most – to diagnose, monitor and inform cancer treatment.

Founded in 1999 by world-renowned cytogeneticist Dr. R.S.K. Chaganti, CGI’s scientific advisory board includes leading specialists in clinical cytogenetics, as well as significant thought leaders capable of driving adoption in the tri-state area.

The company has been built on world-class scientific knowledge and IP in solid and blood-borne cancers, as well as strong academic relationships with major cancer centers such as Memorial Sloan-Kettering and the National Cancer Institute.